Showing results (11-20 of 93) with videos related to
Sort By:
Pageof 10
Stem Cell Reports|June 14, 2023
Nutritional requirements of human induced pluripotent stem cellsDavi M Lyra-Leite, Raymond R Copley, Phillip P Freeman, et al.Pharmacogenomics|January 15, 2021
Use of hiPSC to explicate genomic predisposition to anthracycline-induced cardiotoxicityTarek Magdy, Paul W BurridgeCell Stem Cell|February 9, 2019
Unraveling Difficult Answers: From Genotype to Phenotype in Coronary Artery DiseaseTarek Magdy, Paul W BurridgeStem Cell Reports|January 14, 2020
Negligible-Cost and Weekend-Free Chemically Defined Human iPSC CultureHui-Hsuan Kuo, Xiaozhi Gao, Jean-Marc DeKeyser, et al.Methods in Molecular Biology (Clifton, N.J.)|April 3, 2013
Highly efficient directed differentiation of human induced pluripotent stem cells into cardiomyocytesPaul W Burridge, Elias T ZambidisCell Stem Cell|September 15, 2021
RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapyTarek Magdy, Zhengxin Jiang, Mariam Jouni, et al.Current Cardiology Reports|June 21, 2020
Pluripotent Stem Cell Modeling of Anticancer Therapy-Induced CardiotoxicityDavi M Lyra-Leite, Paul W BurridgeHuman Reproduction (Oxford, England)|June 14, 2012
Inhibition of glycogen synthase kinase-3 promotes efficient derivation of pluripotent stem cells from neonatal mouse testisSeyedeh-Faezeh Moraveji, Farnoosh Attari, Abdolhossein Shahverdi, et al.Journal of Cardiovascular Translational Research|February 21, 2020
Human In Vitro Models for Assessing the Genomic Basis of Chemotherapy-Induced Cardiovascular ToxicityEmily A Pinheiro, Tarek Magdy, Paul W BurridgeMethods in Molecular Biology (Clifton, N.J.)|September 6, 2022
Pharmacogenomic Screening of Drug Candidates using Patient-Specific hiPSC-Derived Cardiomyocyte High-Throughput Calcium ImagingMalorie Blancard, K Ashley Fetterman, Paul W BurridgePageof 10